As more Americans become underinsured or uninsured as a result of rising health insurance premiums and the several changes that were passed in…
Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply…
BioMedWire Editorial Coverage: Today's multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none…
Earth Science Tech has made meaningful progress over the last few years, building a business anchored in a conglomerate model,…
For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to…
Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising. Investors in…
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them…
A recent study that was conducted on 5,617 people diagnosed with colorectal cancer found that while it was uncommon for…
Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations has advanced ONC010…
A preclinical study conducted by a joint team from Switzerland has found that treatment outcomes for glioblastoma patients improved considerably if they received immunotherapy…